Clearbridge Health Ltd.

As of December 31, 2023, Clearbridge Health Ltd. carries a market capitalization of 9.90M, placing it among publicly traded companies globally. Its enterprise value stands at 16.14M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Clearbridge Health Ltd.'s next confirmed earnings release is scheduled for February 26, 2027.

As of December 31, 2023, Clearbridge Health Ltd. has 1.11B shares outstanding.

These figures are as of December 31, 2023.

As of December 31, 2023, Clearbridge Health Ltd. maintains a current ratio of 1.73, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2023.

Over the twelve months ended December 31, 2023, Clearbridge Health Ltd. recorded an income tax benefit of -1.93M rather than an expense, typically from losses, carryforwards, or the release of a tax provision.

As of the close on October 22, 2026, Clearbridge Health Ltd.'s stock has declined approximately 50.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.

As of December 31, 2023, Clearbridge Health Ltd. holds 4.48M in cash and equivalents against 7.64M in total debt, resulting in a net debt position of 1.40M. Total book value stands at 10.19M, with working capital of 3.60M providing operational flexibility.

These figures cover the twelve months ended December 31, 2023.

Clearbridge Health Ltd.'s most recent stock split took place on November 14, 2024 with a 5:9 split ratio.